เดือน: สิงหาคม 2025

HONG KONG, Aug 5, 2025 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK) today announced that the supplemental application for the production expansion of NEFECON® has been officially approved by China’s National Medical Products Administration (NMPA). This approval for production expansion will further boost capacity and increase product supply, enabling a more efficient response to the growing clinical demand in China and across Asia.NEFECON® is the first and only etiological treatment for IgA nephropathy (IgAN) to receive full approval in China, the United States, and Europe, serving as a foundational first-line therapy for patients with IgAN. Since its initial approval in China in November 2023, NEFECON® was subsequently included in the National Reimbursement Drug List (NRDL) in November 2024, and received full approval from the NMPA in May 2025, irrespective of proteinuria levels, benefiting most individuals living with IgAN.NEFECON® specifically modulates the mucosal immune system in the gut to reduce the formation of pathogenic galactose-deficient IgA1 (Gd-IgA1) that trigger IgAN. Results from the Phase 3 clinical study NefIgArd demonstrated that NEFECON® reduces the decline in kidney function by 50%. Results from Phase 3 clinical study NefIgArd of the Chinese population shows that NEFECON® reduces kidney function decline by 66%, and delays disease progression to dialysis or kidney transplantation by 12.8 years.“The expansion of our NEFECON® production capacity will help better meet the growing clinical treatment needs of IgAN patients in China.” Said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “China has one of the highest rates of primary glomerular disease in the world, with more than 5 million patients estimated to be living with IgAN and over 100,000 new cases diagnosed each year. Chinese IgAN patients generally experience faster disease progression and poorer prognosis, highlighting a significant unmet medical need.As the only etiological treatment for IgAN currently recommended by both international and Chinese guidelines, the expansion of NEFECON® production will further accelerate the uptake of etiological treatment, enabling more patients to access standardized treatment earlier to delay disease progression and protect kidney function. We will continue to enhance the accessibility and affordability of NEFECON®, supporting its advancement from ‘changing the treatment landscape’ to ‘redefining the standard of care’.”NEFECON®, as the only in-disease IgAN treatment has been included in the KDIGO 2024 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV) (public review draft), making it the only targeted therapy endorsed by both international and Chinese guidelines. NEFECON® has been approved across all Everest Medicines’ territories, including mainland China, Hong Kong SAR, Macau SAR, Taiwan region, China, as well as Singapore and South Korea, and continues to expand its therapeutic impact across Asia.As production capacity continues to grow and supply capabilities improve, NEFECON® is well positioned to benefit a broader patient population by accelerating the uptake of etiological treatment, enabling more patients to access standardized care earlier to delay disease progression and preserve kidney function. Copyright 2025 ACN Newswire via SeaPRwire.com.

NEW YORK, Aug 4, 2025 - (ACN Newswire via SeaPRwire.com) - Traveler Care, a breakthrough medical dispatch platform that brings urgent care directly to travelers in hotels, Airbnbs, and vacation rentals, has officially launched worldwide - offering travel insurance companies a high-impact solution to reduce avoidable emergency room and hospital claims.Traveler care traveler.care home pageA Concierge Alternative to the Emergency RoomTraveler Care connects travel insurers and their policyholders to a network of licensed, on-call providers who visit travelers in their accommodations - typically within 60-90 minutes. Conditions such as flu, food poisoning, dehydration, allergic reactions, UTIs, sprains, and wound care are treated on-site, eliminating the need for an ER visit."In most cases, travelers just need a doctor - not a hospital admission," said Eli Ofel, founder of Traveler Care. "We've built a scalable, insurer-ready solution that saves money and delivers a far better traveler experience."Reduce Claims by $10,000+ Per VisitOn average, a non-emergency ER visit costs travel insurers $13,000 to $17,000. Traveler Care treats the same conditions in-room for $1,700 to $3,000 - including diagnostics like mobile X-ray, ultrasound, IV therapy, and wound treatment.Pilot results have shown:- 83% reduction in ER claim volume- $10,000+ savings per case avoided- Higher satisfaction scores among travelersBuilt for Travel Insurance PartnersTraveler Care is fully designed for insurance integration - with white-label and API options available for TPAs, underwriters, and global assistance networks.Platform features:- Nationwide U.S. coverage (with international expansion underway)- A robust dispatch network, for example companies like Leaa Health, Sickday, Heal, DocGo and more, any location that the travel insurance is experiencing high volume travel care will create a solution for that particular location within 60 days.- HIPAA-compliant documentation + one-click claims integration- Supports care delivery to hotels, Airbnbs, resorts, and serviced apartmentsNow Onboarding Insurance Companies Worldwide"We believe travel insurance companies shouldn't just pay for care - they should deliver it smarter," said Ofel. "With Traveler Care, you lower claims without compromising care."Insurance providers, TPAs, and global assistance companies are invited to partner and deploy in-room urgent care as part of their medical benefit stack.ContactTo schedule a private demo or receive our ROI case study:Visit www.traveler.careEmail: partners@traveler.carePhone: +1 (347) 733-0563About Eli OfelEli Ofel is a serial entrepreneur and visionary behind multiple AI- and tech-powered platforms in healthcare, finance, and transportation. He is the founder and CEO of Traveler Care, Run.Vet, Leaa Health, 02.Market, and Lender.Market. With over 20 years of experience in healthcare operations, insurance workflows, and mobile logistics, Ofel brings a proven ability to bridge patient needs with scalable platform solutions - saving time, money, and lives.Contact InformationEli OfelCEOeli@traveler.care3477330563SOURCE: Traveler care Copyright 2025 ACN Newswire via SeaPRwire.com.

Boca Raton, Florida--(ACN Newswire via SeaPRwire.com - August 4, 2025) - Atlas Lithium Corporation (NASDAQ: ATLX) ("Atlas Lithium" or "Company"), a leading lithium development company, is pleased to announce that SGS Canada Inc. ("SGS") has completed the Definitive Feasibility Study ("DFS") for the Company's 100%-owned Neves Lithium Project ("Project"), a technical report prepared under the U.S. guidelines of Item 1300 of Regulation S-K ("Regulation S-K 1300"). This hard-rock Project is well-suited to being a low-cost open-pit mining operation, as its spodumene deposits are located relatively close to the surface. Located in the state of Minas Gerais, Brazil, the Project encompasses 4 of the 98 mineral rights for lithium owned by Atlas Lithium. As detailed in the DFS, the Neves Project is expected to deliver strong financial metrics with an internal rate of return ("IRR") of 145%, payback in 11 months from the start of operations, and an after-tax net present value ("NPV") of $539 million. Importantly, the DFS estimates the Neves Project to have operational production costs of only $489 per tonne of lithium concentrate, positioning Atlas Lithium among the world's lowest-cost producers. Complete details of these metrics can be found in the DFS, filed with the Securities and Exchange Commission as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025. Marc-Antoine Laporte from SGS serves as the Qualified Person for the DFS under Regulation S-K 1300. SGS is well-known as a global leader in testing, inspection, and certification services for mineral properties and projects.Industry-Leading Capital Efficiency and Low Operating CostsThe DFS supports that expected direct capital expenditures of $57.6 million will be needed for the implementation of the Project, by far the lowest such capital costs among other announced projects in Brazil. Notably, Atlas Lithium has already invested approximately $30 million in acquiring and transporting the Project's newly fabricated dense media separation ("DMS") plant to Brazil, as previously reported. The Company has secured two non-dilutive pre-payment agreements for its lithium concentrate totaling $40 million and has received additional funding interest from other parties, including 10-year debt financing options, any of which could support the Project's capital requirements.The Company believes that the DFS validates the Project's strong economics, positioning it among the most capital-efficient and lowest-cost hard-rock lithium developments globally. The Project will employ proven DMS technology, with comprehensive metallurgical testing demonstrating an expected robust lithium recovery rate of 61.7% to produce high-quality, low-impurity lithium concentrate. This relatively straightforward, low-risk DMS processing methodology minimizes technical complexity and operational risk while enabling a low environmental footprint.Atlas Lithium's mineral right to be mined, as detailed in the DFS, received its "Portaria de Lavra" (mining concession) status from Brazil's Ministry of Mines and Energy on May 27, 2025 — the highest level of titleship in Brazil and one that allows continuous mining operations. Multiple deposit areas within the Project remain open for resource expansion along strike and at depth and are thus expected to extend the life of mine. Additionally, numerous high-potential geological targets remain within the Project's mineral rights, providing compelling opportunities for future exploration.Located in the established Araçuaí Pegmatite District in the Vale do Jequitinhonha, often called Lithium Valley, the Project benefits from favorable infrastructure, including proximity to transportation networks, water resources, and skilled labor. The Project qualifies for tax incentives from the Superintendency for the Development of the Northeast (SUDENE), as promulgated by Brazil's Ministry of Integration and Regional Development, reducing the corporate tax rate from 34% to 15.25% and further enhancing profitability."The DFS indicates potentially outstanding returns for our initial vision of developing a focused, near-term, profitable lithium production asset with minimal capital requirements," said Marc Fogassa, Chairman and CEO of Atlas Lithium. "The combination of our low capital intensity and rapid payback period is expected to create exceptional value for our shareholders while positioning Atlas Lithium to benefit from future organic expansion opportunities at Neves and other high-potential lithium areas that we own. Importantly, we are creating many quality employment opportunities in the Vale do Jequitinhonha region, representing a significant societal contribution of our Project."Experienced Leadership Driving Project ImplementationFollowing his leadership role in collaborating with SGS on the DFS, project implementation activities are being supervised by Eduardo Queiroz, Atlas Lithium's Project Management Officer (PMO) and Vice President of Engineering. Mr. Queiroz has more than two decades of hands-on experience managing complex, large-scale mining projects."The DFS demonstrates the technical robustness of the Project, with proven DMS technology and comprehensive metallurgical test work validated by SGS, a premier firm in the lithium space," said Mr. Queiroz. "With our processing plant fully fabricated and paid for, and now with the DFS in hand, we have systematically de-risked the Project. I am excited to lead the implementation phase of Atlas Lithium's journey to becoming a lithium producer."Salinas and Clear: The Next Expansion FrontierAtlas Lithium is strategically positioned to capitalize on its extensive regional lithium exploration portfolio in Brazil, particularly through advancement of its Salinas Project and Clear Project, both 100% owned by the Company. Atlas Lithium's Salinas Project is just 5 miles east of the Colina lithium asset previously owned by Latin Resources — a major factor in Pilbara Minerals's acquisition of that company in 2024 for approximately $370 million. At the Salinas Project, Atlas Lithium has already achieved promising initial results, including the discovery of spodumene-rich pegmatites very close to the surface, and highly positive results from soil geochemistry and from LIDAR geological mapping.Atlas Lithium's Clear Project is located less than 4 miles from Sigma Lithium's operating lithium mine, and represents significant untapped potential with highly positive results from soil geochemistry and from LIDAR geological mapping.Diversification in Critical MineralsAtlas Lithium also owns approximately 30% of Atlas Critical Minerals Corporation (OTCQB: JUPGF), a separate company with exploration programs in uranium, rare earths, titanium, and graphite.About Atlas Lithium Corporation Atlas Lithium Corporation (NASDAQ: ATLX) is a lithium development company focused on advancing its Neves Project to production. The Neves Project's Definitive Feasibility Study demonstrates excellent economics with a 145% IRR, $539 million NPV, and an 11-month payback. The Neves Project has received operational permitting, and its dense media separation plant has been acquired and transported to Brazil. With approximately 539 square kilometers of lithium mineral rights, Atlas Lithium owns the largest lithium exploration footprint in Brazil among publicly listed companies. Additionally, Atlas Lithium currently holds an approximate 30% ownership stake in Atlas Critical Minerals Corporation (OTCQB: JUPGF).Safe Harbor StatementThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based upon the current plans, estimates and projections of Atlas Lithium and its subsidiaries and are subject to inherent risks and uncertainties which could cause actual results to differ from the forward-looking statements. Such statements include, among others, those concerning market and industry segment growth and demand and acceptance of new and existing products; any projections of production, reserves, sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements regarding future economic conditions or performance; uncertainties related to conducting business in Brazil, as well as all assumptions, expectations, predictions, intentions or beliefs about future events. Therefore, you should not place undue reliance on these forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: Atlas Lithium's ability to successfully assemble and begin operations of its modular plant; reaching estimated production, development plans and cost estimates for the Neves Lithium Project as reported in the Definitive Feasibility Study (the "DFS"); discrepancies between actual and estimated mineral reserves and mineral resources, between actual and estimated development and operating costs, and between estimated and actual production; results from ongoing geotechnical analysis of projects; business conditions in Brazil; general economic conditions, geopolitical events, and regulatory changes; availability of capital; Atlas Lithium's ability to maintain its competitive position; manipulative attempts by short sellers to drive down our stock price; and dependence on key management.Additional risks related to the Company and its subsidiaries are more fully discussed in the section entitled "Risk Factors" in the Company's Form 10-K filed with the Securities and Exchange Commission (the "SEC") on March 28, 2025, and in the Company's Form 10-Q filed with the SEC on August 4, 2025. Please also refer to the Company's other filings with the SEC, all of which are available at www.sec.gov. In addition, any forward-looking statements represent the Company's views only as of today and should not be relied upon as representing its views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements.Investor RelationsGary GuytonVice President, Investor Relations+1 (833) 661-7900 gary.guyton@atlas-lithium.comhttps://www.atlas-lithium.com/@Atlas_LithiumTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/261106 Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 4, 2025 - (ACN Newswire via SeaPRwire.com) - The “Waste-to-Value, Industry Upgrade, and GBA Co-Creation” Technology Forum (the “Forum”), jointly organized by the GBA Economic and Trade Association, GBA Institute, All-China Environment Federation, and “The Hong Kong University of Science and Technology (HKUST) – Absolute Pure EnviroSci Limited (APEL) Joint Laboratory on Health and Environmental Innovation” under APEL, was successfully convened on 29 July 2025 in Hong Kong. The Forum gathered nearly a hundred innovation and technology experts, industry leaders, and business professionals to explore forward-looking topics such as solid waste management and advanced materials application, smart manufacturing for industry upgrade, low-carbon building materials, policy coordination across Guangdong-Hong Kong-Macao, and leading-edge advances in smart water quality monitoring and purification. By harnessing technological innovation, the Forum seeks to invigorate the circular economy and inject new momentum into the sustainable development of the Greater Bay Area (GBA).The event was graced by an illustrious roster of speakers and honored guests, including Miss Diane Wong, JP, Under Secretary for Environment and Ecology Bureau, the Government of the Hong Kong Special Administrative Region (HKSAR); Mr. Liu Kun, Deputy General Manager, Hunan Construction Investment Group ; Dr. David Chung, Chairman of APEL; Prof. Daniel Cheng, BBS, MH, JP, Honorary President and GBA Honorary Fellow, GBA Economic and Trade Association; Mr. Chan Wing Fai, Deputy Director, All-China Environment Federation; Prof. Yeung King Lun, Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST. These distinguished guests provided strategic and multi-faceted insights into policy, industry, green innovation, and cross-regional collaboration, offering forward-looking recommendations to support the high-quality development of the Greater Bay Area.Miss Diane Wong, JP, Under Secretary for Environment and Ecology Bureau, the Government of HKSAR, said, “To drive the low-carbon transition and seize the economic opportunities presented by green development, Hong Kong has established a robust collaborative framework with Mainland cities in the Guangdong-Hong Kong-Macao Greater Bay Area, actively exploring a regional co-operation model for a ‘Zero-Waste City.’ By harnessing their complementary regional strengths, the Mainland and Hong Kong enhance the recovery and recycling of materials in the Greater Bay Area, thereby advancing the circular economy. Through innovation, partnership, and supportive policies, we can transform environmental challenges into new opportunities. I hope today’s discussion will spark innovative ideas and create more opportunities for collaboration, allowing us to work hand in hand toward a greener future.”Mr. Liu Kun, Deputy General Manager, Hunan Construction Investment Group, highlighted, “The future of technology belongs to courageous pioneers. By uniting the wisdom of ‘Transforming Waste into Value,’ the spirit of ‘Industry Upgrade,’ and the vision of ‘GBA co-creation,’ we will harness the multi-sectoral advantages of investment and infrastructure and make lasting contributions to Hong Kong’s high-quality and sustainable development.”Dr. David Chung, Chairman of APEL, stated, “Technology is the driving force behind economic transformation and higher competitiveness in the new era. By harnessing the power of technology, we seek to ‘Transform Waste into Value’, promote industry upgrades, and accelerate green development. Hong Kong is uniquely positioned—through its entrepreneurial spirit, innovative technologies, robust infrastructure, and global connectivity—to nurture a world-class industrial ecosystem. It is vital that government, industry, academia, research, and investment sectors collaborate closely to advance smart manufacturing, green technology, and high-end manufacturing, while deepening synergies with other cities in the GBA. APEL will continue to align with government policies, foster technological integration and environmental innovation, positioning Hong Kong as a model for new industrialization, driving sustainable development locally and globally.”Prof. Daniel Cheng, BBS, MH, JP, Honorary President and GBA Honorary Fellow, GBA Economic and Trade Association, emphasized “We believe that technological innovation is the cornerstone for high-quality regional economic growth. Today’s forum marks an important step toward a greener, smarter, and more sustainable future. By applying intelligent solid waste processing and resource regeneration technologies, we can significantly reduce environmental burden of waste and transform it into high-value new materials, extending the value chain for green industries and contributing to national goals of carbon peaking and neutrality.”The Forum gathered nearly a hundred innovation and technology experts, industry leaders, and business professionals, including Miss Diane Wong, JP, Under Secretary for Environment and Ecology Bureau, the Government of the HKSAR (fifth from the right); Mr. Liu Kun, Deputy General Manager, Hunan Construction Investment Group (fourth from the right); Mr. Jackin Jim, Chairman of Yee Hop Holdings Limited (fifth from the left); Dr. David Chung, Chairman of APEL (third from the right); Dr. Pat Yeung, Director of APEL (forth from the left), Dr. Willie Lai, Founder of the GBA Economic and Trade Association (first from the left); Prof. Daniel Cheng, BBS, MH, JP, Honorary President and GBA Honorary Fellow, GBA Economic and Trade Association (third from the left); Mr. Chan Wing Fai, Deputy Director, All-China Environment Federation (second from the right); Dr. Chen Weiguang, Director, Digital Low-Carbon Research Institute, Institute of Innovation and Development of Sciences and Technology, Chinese Academy of Sciences (first from the right); and Prof. Yeung King Lun, Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST (second from the left)Fly Ash Recycling Technology Emerges as Key Engine for Circular Economy Development in Greater Bay AreaThe subsequent “Waste-to-Value, Industry Upgrade, and GBA Co-Creation” technology forum brought together experts and industry leaders from various fields for in-depth discussions on three major themes, injecting fresh insights into green technology and regional industrial upgrading. China’s Solid Waste Pollution Prevention and Control Law mandates the safe disposal and resource utilization of fly ash to minimize environmental pollution. Ms. Huang Jing, Deputy Manager, Overseas Division, Hunan Construction Investment Group, analyzed the advantages and case studies of multi-source solid waste (including fly ash and sludge) treatment and integration with new materials.Dr. Chen Weiguang, Director of the Digital Low-Carbon Research Institute, Institute of Innovation and Development of Sciences and Technology, Chinese Academy of Sciences, highlighted that since 2030, China has been progressively reducing landfill disposal of fly ash, encouraging regions with the necessary conditions to achieve zero landfill for incineration residues. Conventional chelation and landfill methods for fly ash—which contains chlorides, heavy metals, and dioxins—are being replaced by innovative two-step processing technology. This approach enables high-value resource recovery, establishing a complete industrial value chain and offering a scalable, replicable solution for near-zero solid waste landfill globally.At the forum, moderator Dr. David Chung, Chairman of APEL (left), together with Dr. Chen Weiguang, Director, Digital Low-Carbon Research Institute, Institute of Innovation and Development of Sciences and Technology, Chinese Academy of Sciences (center) and Ms. Huang Jing, Deputy Manager, Overseas Division, Hunan Construction Investment Group (right) engaged in a discussion on waste resource utilization and circular technologies.In the realm of new industrialization and smart manufacturing, Ir. Raymond Shan, General Manager, New Industrialisation Division, Hong Kong Productivity Council (HKPC), and Dr. Alex Choi, Biomedical Specialist, New Industrialisation Division, HKPC shared insights on how automation, digitalization, and AI-driven solutions are advancing upgrade of industries. Ir. Raymond Shan, General Manager of the New Industrialisation Division of HKPC, stated: “Hong Kong is entering a 'New Quality Era'. The HKSAR Government has launched the 'New Industrialisation Funding Scheme (NIFS)' and 'New Industrialisation Acceleration Scheme (NIAS)', which aim to subsidise enterprises engaged in smart and green manufacturing to establish new smart production lines in Hong Kong. HKPC is also cultivating future engineers through a series of future skills training programs, while promoting development in emerging fields such as new energy, bio-health, advanced manufacturing, new materials and artificial intelligence, to consolidate Hong Kong's position as an international innovation hub.”Dr. Alex Choi, Biomedical Specialist of the New Industrialisation Division of HKPC, stated: “In HKPC's initiatives and projects to commercialize R&D achievements in Hong Kong's life & health and new energy industries, we have collaborated with a local enterprise to promote the development of the hydrogen energy sector. The plan includes building Hong Kong's first green hydrogen production facility that will utilize natural biogas from landfills to produce hydrogen. The hydrogen produced at this facility complies with the GB/T 37244-2018 quality standard with purity ≥99.97%, and is suitable not only for transportation use but also for various downstream applications.”At the forum, moderator Dr. David Chung, Chairman of APEL (left), together with Ir. Raymond Shan, General Manager, New Industrialisation Division, HKPC (center) and Dr. Alex Choi, Biomedical Specialist, New Industrialisation Division, HKPC (right) engaged in a discussion on new industrialization and smart manufacturing.On innovative smart water management, Prof. Han Wei, Research Associate Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST, along with Mr. Billy Luk, Chief Application Scientist at the HKUST–APEL Joint Laboratory, presented the latest breakthroughs in smart water quality monitoring and efficient purification technologies. Mr. Billy Luk said, “Water is an essential resource for sustaining human life and ecological health. Wisepura Aquapura, developed by APEL, utilizes world’s first patented porous silica capsule technology, which intelligently releases active ingredients upon contact with water. This effectively targets over 30 types of over 30 types of bacteria, fungi, and viruses in water supply, air conditioning, and sewage systems while also meeting diverse application needs. Currently, this innovative technology is widely applied across Hong Kong’s public infrastructure. More importantly, the silica capsule can be reused multiple times and safely disposed of at the end of its lifecycle, thereby minimizing environmental impact.”Prof. Han Wei, Research Associate Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST (left) and Mr. Billy Luk, Chief Application Scientist at the HKUST–APEL Joint Laboratory (right) presented the latest breakthroughs in smart water quality monitoring and efficient purification technologies at the forum.About All-China Environment FederationAll-China Environment Federation (ACEF) is a nationwide non-profitable civil society organization (CSO) in the field of the environment, and is supported by the government. It is composed of CSOs and individuals who are enthusiastic about and support environmental protection and are willing to work for it. The objective of ACEF is to serve as a bridge between the government and the public in implementing the sustainable development strategy, achieving national objectives on environment and development, and protecting the environmental rights of the public. By fully utilizing its organizational advantage, ACEF aims to promote environmental protection and sustainable development in China and the world at large.About GBA Economic and Trade AssociationThe GBA Economic and Trade Association is an economic, trade and financing matching platform initiated and established by business leaders and social elites. Its vision and mission is to cooperate with national policies, assist the economic development of the Greater Bay Area, and provide diversified policy research, analysis and advice, make use of the different advantages and resources of different regions in the region, strengthen economic and trade cooperation, open up four streams: talent flow, goods flow, capital flow and information flow, and accelerate the development of the Bay Area into a world-leading economy.About GBA InstituteThe GBA Institute, founded by the GBA Economic and Trade Association, aims to support the national strategy for the Greater Bay Area's development. Its mission is to cultivate global business leaders and uphold Hong Kong's position as a leading international financial center. The institute partners with prestigious global universities to offer high-level training programs and recognizes outstanding contributors from politics, business, and academia who have made significant contributions to society and the development of the Greater Bay Area.About Absolute Pure EnviroSci LimitedAbsolute Pure EnviroSci Limited (“APEL”), is an indirect non-wholly owned subsidiary of Yee Hop Holdings Limited, a company listed on the Main Board of the Stock Exchange of Hong Kong Limited (stock code: 1662.HK). With a mission to improve the quality of life and living environments, APEL is principally engaged in the research and development and commercialization of health and environmental innovations. Leveraging its Multilevel Antimicrobial Polymer (MAP-1) technology, APEL has developed specialized application formulas in four key areas: air purification in aircraft, water purification, livestock health, and eco-friendly building materials, all designed to address pressing global challenges. On 10 January 2024, APEL jointly established the “HKUST-APEL Joint Laboratory on Health and Environmental Innovation” with the Hong Kong University of Science and Technology (HKUST) to develop and translate novel discoveries into groundbreaking health and environmental innovations. APEL looks forward to working with researchers and industry partners worldwide to drive further health and environmental innovations. To tap into the global health and environmental hygiene market, APEL is currently holding an innovative interactive exhibition at The Lab. in Osaka to showcase its three flagship products—Wisepura water and air purification systems, GERMAGIC™ antimicrobial coating, and GERMAGIC™ PET health care solutions for pets—seizing growth opportunities in Asia’s health technology industry.For inquiries, please contact:AJA (IR & Communications)Avy YuTel: (852) 9500 4443Email: avy.yu@ajacapital.com.hk / info@ajacapital.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.